Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) Revenue (2021 - 2025)

Biote (BTMD) has 3 years of Revenue data on record, last reported at $45.7 million in Q4 2023.

  • For Q4 2023, Revenue rose 2.74% year-over-year to $45.7 million; the TTM value through Sep 2024 reached $45.7 million, down 75.18%, while the annual FY2024 figure was $197.2 million, 6.38% up from the prior year.
  • Revenue reached $45.7 million in Q4 2023 per BTMD's latest filing, roughly flat from $45.6 million in the prior quarter.
  • Across five years, Revenue topped out at $49.3 million in Q2 2023 and bottomed at $34.8 million in Q2 2021.
  • Average Revenue over 3 years is $41.7 million, with a median of $42.0 million recorded in 2022.
  • The widest YoY moves for Revenue: up 20.73% in 2023, down 2.74% in 2023.
  • A 3-year view of Revenue shows it stood at $37.5 million in 2021, then grew by 18.51% to $44.5 million in 2022, then rose by 2.74% to $45.7 million in 2023.
  • Per Business Quant database, its latest 3 readings for Revenue were $45.7 million in Q4 2023, $45.6 million in Q3 2023, and $49.3 million in Q2 2023.